Electrocardiograms
JE · Effective Oct 1, 2015
33 active Medicare policies list E75.22, and 6 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
JE · Effective Oct 1, 2015
JF · Effective Oct 1, 2015
J15 · Effective Oct 5, 2015
JE · Effective Jun 1, 2016
JF · Effective Jun 1, 2016
JJ · Effective Oct 5, 2015
JM · Effective Oct 5, 2015
J5 · Effective Jun 16, 2016
J8 · Effective Jun 16, 2016
6 policies from 5 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of E75.22 |
|---|---|---|
| Home Cholesterol Monitors | Jun 21, 2023 | Covered |
| Homocysteine Testing | Oct 26, 2023 | Covered |
| Policy | Effective | Status of E75.22 |
|---|---|---|
| Concert Genetic Testing: Toxicology and Pharmacogenetics Version B | Not recorded | Referenced |
| Policy |
|---|
J6 · Effective Jul 13, 2025
JK · Effective Jul 13, 2025
J9 · Effective Dec 12, 2021
JH · Effective Dec 12, 2021
JL · Effective Dec 12, 2021
J9 · Effective Oct 1, 2015
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
J15 · Effective Oct 1, 2015
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
National · Effective Oct 1, 2026
J5 · Effective Oct 1, 2025
National · Effective Oct 1, 2026
National · Effective Oct 1, 2026
National · Effective Oct 1, 2025
J5 · Effective Oct 1, 2026
J6 · Effective Apr 1, 2026
JL · Effective Sep 10, 2026
J9 · Effective Sep 10, 2026
JL · Effective Oct 1, 2025
National · Effective Oct 1, 2025
National · Effective Aug 6, 2026
J6 · Effective Apr 1, 2026
| Effective |
|---|
| Status of E75.22 |
|---|
| Hematopoietic Stem Cell Transplantation for Genetic Diseases and Aplastic Anemias | May 28, 2026 | Covered |
|---|
| Policy | Effective | Status of E75.22 |
|---|---|---|
| Infant Nutritional Formula | Sep 15, 2026 | Covered |
| Policy | Effective | Status of E75.22 |
|---|---|---|
| Intravenous Enzyme Replacement Therapy (ERT) for Gaucher Disease | Jun 1, 2026 | Covered |